STAT+: How insurers are covering Humira and copycat medicines

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday.

What to make of the 2025 Medicare enrollment season

In four weeks, Medicare beneficiaries will be able to sign up for 2025 coverage. And for the roughly 34 million people who are in a Medicare Advantage plan, things likely will look a lot different (and be as confusing as ever), my colleague Tara Bannow reports.

CVS Health and Humana have been the most vocal major insurers about scaling back their Medicare Advantage plan offerings to improve profits. It’s a bit of cold water on an industry that has spent the past decade doing everything in its power to get more people into Medicare Advantage.

Continue to STAT+ to read the full story…

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!